Carbosilane dendrimers inhibit α-synuclein fibrillation and prevent cells from rotenone-induced damage

Int J Pharm. 2015 Apr 30;484(1-2):268-75. doi: 10.1016/j.ijpharm.2015.02.066. Epub 2015 Feb 28.

Abstract

This study investigates the role of carbosilane dendrimers in fibrillation of α-synuclein and prevention of the mouse hippocampal cell (mHippoE-18) from rotenone-induced damage. Examining the interaction between carbosilane dendrimers and α-synuclein, we found that the dendrimers inhibit fibril formation. We also investigated cell viability, the production of reactive oxygen species (ROS), and mitochondrial membrane potential. mHippoE-18 cells were preincubated with carbosilane dendrimers before rotenone was added. All the dendrimers possess potential protection activity. Preincubation with dendrimers contributed to: increased viability, higher mitochondrial membrane potential, and reduced ROS level in cells. The probable mechanism of cell protection lies in the ability of dendrimers to capture rotenone by encapsulating or binding to its surface groups. The fact that dendrimers have prevention potential is important in the search for new pharmacological strategies against neurodegenerative disorders.

Keywords: Carbosilane dendrimers; Parkinson’s disease; Rotenone; α-Synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cell Survival / drug effects*
  • Cell Survival / physiology
  • Dendrimers / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Mice
  • Reactive Oxygen Species / metabolism
  • Rotenone / toxicity*
  • Silanes / pharmacology*
  • alpha-Synuclein / antagonists & inhibitors*
  • alpha-Synuclein / metabolism

Substances

  • Dendrimers
  • Reactive Oxygen Species
  • Silanes
  • alpha-Synuclein
  • carbosilane
  • Rotenone